23 Jul Venture group creates health care incubator in Tampa’s Hyde Park – Tampa Bay Business Journal
An innovative accelerator in South Florida has partnered with a Tampa General Hospital executive to create a think tank aimed at preventing opioid abuse. The Center for Analgesic Transformation is created by the collaboration of South Florida Accelerator LLC, an innovation aggregator and early stage venture fund, and Pacira Pharmaceuticals Inc. along with Dr. Devanand Mangar, the chief of anesthesiology at Tampa General Hospital and president and CEO of Tampa Outpatient Surgical Facility and North Tampa Outpatient Surgical facility.
“When we came to Tampa, we wanted to focus on health care and said we can be very good at this one thing. There’s intellectual capital around health care in the bay area,” Thomas Buchar, managing partner with TSFA, told the Tampa Bay Business Journal.
The center, now open in Hyde Park at 809 S. Albany Ave., is a think tank committed to developing opioid minimization solutions through the utilization of non-opioid analgesics. In Fort Lauderdale, the accelerator focuses on the fintech space, and Buchar said he is using the same approach in Tampa with the help of the new partners.
“We all said we want to create a center of excellence around health care and we need to attack the opioid epidemic. We’ve got to approach the opioid crisis as we attack the banking industry. You have to use the same discipline with all three parties coming together. Nobody else is doing this, everybody is approaching the epidemic from a reactive point of view where they are treating the addict, but there’s no think tank in how to prevent it,” Buchar said. The Center for Analgesic Transformation will work to educate clinicians and patients on the burden of post-surgical opioids as an unintended gateway to misuse and addiction, and develop opioid minimization strategies to reduce its use following surgical procedures.
“Reducing unnecessary exposure to opioids following surgery is an essential component for preventing opioid addiction before it begins,” said David Stack, chairman and CEO of Pacira, in the July 17 news release.